Vivani Medical, Inc.
VANI
$1.34
$0.010.91%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.21M | 2.70M | 2.34M | 2.16M | 2.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.73M | 7.46M | 6.56M | 6.46M | 6.31M |
| Operating Income | -6.73M | -7.46M | -6.56M | -6.46M | -6.31M |
| Income Before Tax | -6.53M | -7.14M | -6.30M | -6.05M | -6.04M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.53M | -7.14M | -6.30M | -6.05M | -6.04M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.53M | -7.14M | -6.30M | -6.05M | -6.04M |
| EBIT | -6.73M | -7.46M | -6.56M | -6.46M | -6.31M |
| EBITDA | -6.62M | -7.36M | -6.46M | -6.37M | -6.20M |
| EPS Basic | -0.11 | -0.12 | -0.11 | -0.11 | -0.11 |
| Normalized Basic EPS | -0.07 | -0.08 | -0.07 | -0.07 | -0.07 |
| EPS Diluted | -0.11 | -0.12 | -0.11 | -0.11 | -0.11 |
| Normalized Diluted EPS | -0.07 | -0.08 | -0.07 | -0.07 | -0.07 |
| Average Basic Shares Outstanding | 59.71M | 59.24M | 59.24M | 57.42M | 55.25M |
| Average Diluted Shares Outstanding | 59.71M | 59.24M | 59.24M | 57.42M | 55.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |